Last viewed:
INM
Prices are updated after-hours
INM
4
|
$0.29
6.23%
-1.49%
3.3M
|
Health Technology
(0.0% 1d)
(-25.0% 1m)
(-76.5% 1y)
(0.0% 2d)
(-3.6% 3d)
(-10.0% 7d)
(-53.64%
volume)
Earnings Calendar: 2023-02-13
Market Cap: $ 1,756,521
http://www.inmedpharma.com
Sec
Filling
|
Patents
| n/a employees
InMed Pharmaceuticals, Inc. engages in the research and development of cannabinoid-based therapies and biosynthesis system for the manufacturing of pharmaceutical-grade cannabinoids. It offers pipeline of medications that target diseases with unmet medical needs, such as epidermolysis bullosa, glaucoma, and orofacial pain. The company was founded by Christopher Bogart, Sazzad Hossain, Hyder A. Khoja, and Craig D. Schneider on May 19, 1981 and is headquartered in Vancouver, Canada.
add to watch list
Paper trade
email alert is off
Press-releases
Focus Impact Partners Announces Acquisition of Sponsor Interest in … – Business Wire
Published: 2023-11-08
(Crawled : 00:00)
- spacfeed.com
INM
4
|
$0.29
6.23%
-1.49%
3.3M
|
Health Technology
| -35.68%
| O: -0.19%
H: 0.24%
C: -9.55%
business
acquisition
impact
Why Milk Makeup's Parent Company Is Facing a Nasdaq Delisting – msnNOW
Published: 2023-11-08
(Crawled : 23:00)
- spacfeed.com
INM
4
|
$0.29
6.23%
-1.49%
3.3M
|
Health Technology
| -35.68%
| O: -0.19%
H: 0.24%
C: -9.55%
nasdaq
company
S-4 – Iris Parent Holding Corp. (0001971387) (Filer)
Published: 2023-11-08
(Crawled : 23:00)
- spacfeed.com
INM
4
|
$0.29
6.23%
-1.49%
3.3M
|
Health Technology
| -35.68%
| O: -0.19%
H: 0.24%
C: -9.55%
iris
Lilly Announces Extension of Tender Offer to Acquire POINT … – PR Newswire
Published: 2023-11-08
(Crawled : 00:00)
- spacfeed.com
INM
4
|
$0.29
6.23%
-1.49%
3.3M
|
Health Technology
| -35.68%
| O: -0.19%
H: 0.24%
C: -9.55%
acquire
extension
VinFast Stock Is Ripping Higher. There Is No Reason. – Barron's
Published: 2023-11-08
(Crawled : 00:00)
- spacfeed.com
INM
4
|
$0.29
6.23%
-1.49%
3.3M
|
Health Technology
| -35.68%
| O: -0.19%
H: 0.24%
C: -9.55%
Epidermolysis Bullosa Market to Surge at a CAGR of ~8% During the Study Period (2019-2032), Predicts DelveInsight
Published: 2023-08-10
(Crawled : 21:00)
- prnewswire.com
INM
4
|
$0.29
6.23%
-1.49%
3.3M
|
Health Technology
| -72.16%
| O: -4.91%
H: 7.68%
C: -2.42%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
| -12.35%
| O: -1.27%
H: 0.0%
C: 0.0%
ONTX
|
$0.9953
-5.61%
1.3M
|
Health Technology
| -1.96%
| O: -1.96%
H: 0.0%
C: -3.99%
KRYS
|
News
|
$159.05
-1.85%
-1.88%
240K
|
Health Technology
| 34.17%
| O: -0.53%
H: 1.74%
C: -0.98%
study
market
InMed Reports Second Quarter Fiscal 2023 Financial Results and Provides Business Update
Published: 2023-02-17
(Crawled : 22:00)
- globenewswire.com
INM
4
|
$0.29
6.23%
-1.49%
3.3M
|
Health Technology
| Email alert
Add to watchlist
financial
update
results
InMed Submits Form 12b-25
Published: 2023-02-10
(Crawled : 03:00)
- globenewswire.com
INM
4
|
$0.29
6.23%
-1.49%
3.3M
|
Health Technology
| -85.75%
| O: -2.9%
H: 4.35%
C: 3.8%
InMed Provides Business Update and Milestones for 2023
Published: 2023-01-10
(Crawled : 14:00)
- biospace.com/
INM
4
|
$0.29
6.23%
-1.49%
3.3M
|
Health Technology
| -84.02%
| O: 9.47%
H: 30.27%
C: 24.32%
update
InMed Announces Results of 2022 Annual General Meeting
Published: 2022-12-15
(Crawled : 00:00)
- globenewswire.com
INM
4
|
$0.29
6.23%
-1.49%
3.3M
|
Health Technology
| -85.48%
| O: -3.76%
H: 4.75%
C: -0.56%
meeting
results
See all
Last 15 days Sec forms
File Id
Form
Published Date
Transaction Date
Direction
Code
Amount Transacted
Owned Amount
0001213900-24-020088
4
2024-03-05
2024-01-14
Sell
H
42
8542